Takeda Held Responsible in First Federal Actos Bellwether Trial

After 34 days of trial, a Lafayette, Louisiana jury returned its verdict against Takeda and Lilly and ordered the PHARMA giants to pay $1.475 million in compensatory damages and $8 billion in punitive damages for injuries including bladder cancer to Terrance Allen, a hardware store manager, who took Actos for his diabetes treatment from 2004 [...]

April 8th, 2014|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Takeda Held Responsible in First Federal Actos Bellwether Trial

Actos Trial Underway in Louisiana

Terry Allen, a retired hardware store manager is the plaintiff in the case currently in trial against pharmaceutical giant Takeda, the manufacturer of Actos, the diabetes drug that Allen and his experts say caused him to have bladder cancer. (See In Re Actos (Pioglitazone) Products Liability Litigation, 11-md-02299; Allen’s case is Allen v. Takeda Pharmaceuticals [...]

February 12th, 2014|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Actos Trial Underway in Louisiana

Takeda’s Future after Losing Actos Patent

In 2012, Takeda’s profit dropped 53% and net profit was down 14% in the last nine months of 2012. Why? Because medical studies have demonstrated the causal connection between Takeda’s flagship diabetes drug Actos and bladder cancer and Takeda also lost its exclusivity patent on its foundation product diabetes treatment.  Actos accounted for more than [...]

August 26th, 2013|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Takeda’s Future after Losing Actos Patent